Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
Filters
Simon Garnier
Assistant Professor, College of Science and Liberal ArtsNew Jersey Institute of Technology
Professor Garnier focuses on the study of collective behaviors and swarm intelligence in natural and artificial systems
Cliff Schecter
Principal & PresidentLibertas, LLC
Enter Stage Left: Liberate your perspective with Libertas's progressive PR guy, columnist, We Act Radio co-founder, and bestselling author
Joel Paul
Albert Abramson '54 Professor of LawUC Hastings College of the Law
Contacts: paulj@uchastings.edu / 415-565-4638 / Office 312-200
Riqiang Yan
Professor and Chair, Department of NeuroscienceUniversity of Connecticut
Professor Yan is an expert in neurodegenerative diseases, specializing in identifying the biological culprits behind Alzheimer’s disease.
Kelly Haws
Anne Marie and Thomas B. Walker, Jr. Professor of MarketingVanderbilt University
Expert in food consumption choices, dieting, financial decision making, and self-control in consumption.
Anthony Greenfield
DirectorThe 5 Forces of Change
Leading speaker, author and practitioner of change leadership - entertaining and thought provoking seminars and workshops at major conferenc
Peter G. Klein, Ph.D.
Professor of EntrepreneurshipBaylor University
Expert economist specializing in managerial & organizational issues, with a particular focus on entrepreneurship & innovation
Sandra M. Chafouleas
Board of Trustees Distinguished Professor of Educational PsychologyUniversity of Connecticut
Professor Chafouleas is an expert on whole child, school mental health, behavioral assessment, and K12 tiered systems of support.
Sophie Bjork-James
Assistant Professor of the Practice in AnthropologyVanderbilt University
Expert on the U.S.-based religious right and the white nationalist movement, particularly online communities.
Dr. Mark Ware
Chief Medical OfficerCanopy Growth
Dr. Ware leads Canopy Growth’s medical division, Spectrum Therapeutics including research towards the development of cannabinoid medicines.